Revolution Medicines- Warrants (17/12/2026) Total Assets

The latest total assets for RVMDW is $4.3B as of September 2026. That compares with $2.3B in the prior-year period — up 91.1% year over year. Investors often review this figure alongside Revolution Medicines- Warrants (17/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, RVMDW's total assets moved from $2.3B to $4.3B — a 91.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Revolution Medicines- Warrants (17/12/2026)'s operating scale or balance-sheet position.

A total assets figure of $4.3B for RVMDW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RVMDW's total assets ($4.3B), review year-over-year change from $2.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Revolution Medicines- Warrants (17/12/2026)'s total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.